We have built two broad and agile platforms that allow us to rapidly respond to areas of medical unmet need. Our bacteriophage therapeutics are designed to precisely remove pathogenic bacteria from the human body or leverage the microbiome to deliver precision medicines. Our award-winning manufacturing facility allows us and our partners to rapidly produce drug products for clinical development and early commercial launch.
Locus Biosciences has built a powerful biopharmaceutical development platform that enables us to develop products that selectively remove bacterial species or exploit bacteria to produce payloads that may be beneficial in treating diseases in multiple therapeutic areas.
Locus Biosciences has built an ISPE 2021 Facility of the Year award-winning, world-class biologics manufacturing facility, enabling the manufacture of precision therapeutics.